Estudo randomizado | Efeitos do eptinezumabe intravenoso vs. placebo sobre a cefaleia e outros sintomas quando administrado no início de uma crise de enxaqueca.
18 Jun, 2021 | 10:27hEffects of Intraven.ous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Editorial: Acute Treatment for Migraine: Contemporary Treatments and Future Directions (gratuito por tempo limitado)
Comentário: Migraine Prevention Drug Eptinezumab Shows Efficacy in Treating Acute Attacks – Physician’s Weekly
Comentário no Twitter (fio – clique para saber mais)
Science marches breathlessly forward – or, at least tries to expand its indication.
Anti–calcitonin gene-related peptide antibody infusion, again, vs. placebo.
— Ryan Radecki, MD MS (@emlitofnote) June 17, 2021